Bio_Spectrum_July_2017

(^4) BIOContent BioSpectrum | July 2017 | http://www.biospectrumindia.com
BIOTALK BIOSPECIAL
BIOANALYSIS
32
“We are excited to be a
part of this life sciences
industry”
Peter Salazar
Head, Process solutions India, Merck
34
Competition
is getting
fierce among
the
‘HEALTH
STARTUPS’ IN
INDIA
40
GST to have
constructive
effect on the
Pharma
and
Healthcare
sectors
Innovative biopharmaceutical companies around the world continue to strive to accelerate the pace of
innovation and deliver effective medicines to patients quickly and efficiently. By investing more time, energy,
and resources in collaboration across the R&D ecosystem and leveraging more sophisticated research and
manufacturing tools, these companies in India continue to invest in R&D and advance the science forward.
COVERSTORY ................................................................................................................................................................................. 25
GLOBAL PHARMA CONTINUES TO SEE
POTENTIAL IN INVESTING IN R&D IN INDIA
34 Competition is getting fierce among the ‘HEALTHSTARTUPS’ IN INDIA 40 GST to have a constructiveeffect on the Pharma andHealthcare sectors
Volume 15 Issue 07 July 2017
COVER
DESIGN BY:
thirdconcept design